Bilegtsaikhan Tsolmongyn

A novel mechanism for inhibition of lipopolysaccharide-induced proinflammatory cytokine production by valproic acid

Ulziisaikhan Jambalganiin, Bilegtsaikhan Tsolmongyn, Naoki Koide et al. · International Immunopharmacology · 2014 · 23 citations

Inflammation, Cytokine, Novel Mechanism +9

A Toll‐like receptor 2 ligand, <scp>P</scp>am3<scp>CSK</scp>4, augments interferon‐γ‐induced nitric oxide production via a physical association between MyD88 and interferon‐γ receptor in vascular endothelial cells

Bilegtsaikhan Tsolmongyn, Naoki Koide, Ulziisaikhan Jambalganiin et al. · Immunology · 2013 · 20 citations · Full text

Nitric Oxide, Immunology, Immune Regulation +23

Lipopolysaccharide prevents valproic acid-induced apoptosis via activation of nuclear factor-κB and inhibition of p53 activation

Bilegtsaikhan Tsolmongyn, Naoki Koide, Erdenezaya Odkhuu et al. · Cellular Immunology · 2013 · 18 citations

Lipopolysaccharide Prevents, Chemoprevention Strategy, Medicine +9

Augmentation of LPS-induced vascular endothelial cell growth factor production in macrophages by transforming growth factor-β1

Naoki Koide, Erdenezaya Odkhuu, Yoshikazu Naiki et al. · Innate Immunity · 2013 · 16 citations

Vegf Production, Human Growth, Lung Inflammation +23

Inhibition of receptor activator of nuclear factor-κB ligand (RANKL)-induced osteoclast formation by pyrroloquinoline quinine (PQQ)

Erdenezaya Odkhuu, Naoki Koide, Abedul Haque et al. · Immunology Letters · 2011 · 15 citations

Nuclear Factor-κb Ligand, Medicine, Bone Homeostasis +6